eTable 5. Analysis of the second primary endpoint EQ-5D-5L—full model in the intention-to-treat population.

	Group comparison team-based − standard
	Model coefficient*	95% confidence interval	p value
(Intercept)	0.43	[0.31; 0.56]	< 0.001
Baseline EQ-5D-5L	−0.41	[−0.48; −0.34]	< 0.001
Male sex	0.05	[0.01; 0.09]	0.017
Age (per 10 years)	−0.03	[−0.04; −0.01]	0.001
New form of care	0.02	[−0.02; 0.05]	0.285
Psoriatic arthritis	0.00	[−0.04; 0.05]	0.832

* estimated using a linear mixed model with the variables listed and with a random center effect

EQ-5D-5L, EuroQol in 5 dimensions and 5 response levels